STRUCTURED FRESH APPLE CONSUMPTION FOR BIRCH POLLEN FOOD ALLERGY SYNDROME IN AN UNCONTROLLED PHASE II/III TRIAL

Immunodeficiency

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Clin Immunol

Rao VK, Šedivá A, Dalm VASH, Plebani A, Schuetz C, Shcherbina A, Trizzino A, Zharankova Y, Orpia A, Kulm E, Webster S, Körholz J, Lougaris V, Rodina Y, Conlon N, Coulter T, Bradt J, Relan A, Uzel G

doi: 10.1016/j.clim.2024.110400

Osteoarthritis

Impact of Structural Severity on Outcomes in Knee Osteoarthritis: An Analysis of Data from Phase 2 and Phase 3 Lorecivivint Clinical Trials

Rheumatology (Oxford)

Tambiah J, Kennedy S, Swearingen C, McAlindon T, Yazici Y

doi: 10.1093/rheumatology/keae610

Immunotherapy

The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial

Allergy

Gappa M, Gagnon R, Horak F, Cichocka-Jarosz E, Dalgaard T, Hargreaves K, Mikler J, Emeryk A, Hansen KS, Pfaar O

doi: 10.1111/all.16363

Allergic Diseases

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial

Allergy

Zielen S, Bernstein JA, Sturm GJ, Jutel M, Pfaar O, RESONATE Investigator Group, Shamji MH, Mösges R, Berger M, Berger UE, DuBuske L, Layhadi JA, Klimek L, Ollert M, Skinner MA, Kramer MF, de Kam PJ

doi: 10.1111/all.16491

Allergic Diseases

The effect of early food introduction and skin emollients on pollen sensitization: a randomized trial (PreventADALL) sub-study

J Allergy Clin Immunol Pract

Gerdin SW, Skjerven HO, Konradsen JR, Borres MP, Granum B, Jonassen CM, LeBlanc M, Nilsen M, Rehbinder EM, Rudi K, Staff AC, Söderhäll C, van Hage M, Vettukattil R, Lødrup Carlsen KC, Nordlund B

doi: 10.1016/j.jaip.2025.03.046

Allergic Diseases

Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial

Allergy

Holzmann C, Karg J, Reiger M, Kharbal R, Romano P, Scheiwein S, Khalfi C, Muzalyova A, Brunner JO, Hammel G, Damialis A, Traidl-Hoffmann C, Plaza MP, Gilles S

doi: 10.1111/all.16558

Allergic DiseasesFurther Publications Immunology

Strategic Directions for Advancing Equity in Food Allergy: Takeaways from CFAAR's Summit for Advancing Equity in Food Allergy

J Allergy Clin Immunol Pract

Yang MS, Warren CM, Engel ML, Samady W, Sansweet SR, Kanaley MK, Folger EVW, Shankar S, Gupta RS, Bilaver LA

doi: 10.1016/j.jaip.2025.05.024

Further Publications Immunology

A Streamlined Strategy for Basophil Activation Testing in a Multicenter Phase III Clinical Trial

J Allergy Clin Immunol Pract

Suárez-Fariñas M, Grishin A, Arif-Lusson R, Bourgoin P, Matthews K, Campbell DE, Busnel JM, Sampson HA

doi: 10.1016/j.jaip.2024.09.007

Further Publications Dermatology

Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials

J Eur Acad Dermatol Venereol

Calabrese L, Cartocci A, Rubegni P, French LE, Kendziora B

doi: 10.1111/jdv.20617

Related content

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Impact of Structural Severity on Outcomes in Knee Osteoarthritis: An Analysis of Data from Phase 2 and Phase 3 Lorecivivint Clinical Trials

The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trial

Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III Trial

The effect of early food introduction and skin emollients on pollen sensitization: a randomized trial (PreventADALL) sub-study

Clinical Benefits of a Randomized Allergy App Intervention in Grass Pollen Sufferers: A Controlled Trial

Strategic Directions for Advancing Equity in Food Allergy: Takeaways from CFAAR's Summit for Advancing Equity in Food Allergy

A Streamlined Strategy for Basophil Activation Testing in a Multicenter Phase III Clinical Trial

Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials